Tissue Engineered Skin Substitute Market Projected to Reach US$ 3.5 Billion by 2034 | Future Market Insights, Inc.
April 08, 2024 09:30 ET
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, April 08, 2024 (GLOBE NEWSWIRE) -- The tissue engineered skin substitute market is expected to reach a value of US$ 2.4 billion in 2024, with projections indicating a growth to US$ 3.5...
BioStem Technologies Commends OIG's Recommendation for CMS to Address ASP Reporting Requirements for Skin Substitute Products
March 23, 2023 07:30 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., March 23, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies (“BioStem” or the “Company”) (OTCQB: BSEM), a leading provider of innovative regenerative medicine solutions, is...
Medovex Corporation Announces Recent Management Appointments
April 29, 2019 08:00 ET
|
Medovex Corp.
ALPHARETTA, Ga., April 29, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex” or the “Company”), the owner and operator of innovative medical technology products and services...
Medovex Corporation Closes Financing for a Total $7.2M Under Existing Securities Purchase Agreement
April 08, 2019 08:50 ET
|
Medovex Corp.
ALPHARETTA, Ga., April 08, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex” or the “Company”) today announced that on April 1, 2019, the Company entered into a securities...
Medovex Corporation Announces Name Change and Full Rebranding to Blue Zone Health
February 04, 2019 08:00 ET
|
Medovex Corp.
ALPHARETTA, Ga., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex” or the “Company”) today announced it is now Blue Zone Health. The announcement signals the company's...
Medovex Corporation Receives an Additional $2.9 Million Under Existing Securities Purchase Agreement
January 28, 2019 08:00 ET
|
Medovex Corp.
ALPHARETTA, Ga., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex” or the “Company”) today announced that on January 18, 2019, the Company entered into a securities...
Medovex Corporation Announces New Board Appointments
January 15, 2019 08:30 ET
|
Medovex Corp.
ALPHARETTA, Ga., Jan. 15, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex” or the “Company”) today named Michael Yurkowsky, founder of YP Holdings, and Raymond Monteleone,...
Medovex Corporation Closes Acquisition of Pulmonary Biomedical Services and Patient Delivery Platform of Regenerative Medicine Solutions, LLC
January 14, 2019 08:00 ET
|
Medovex Corp.
ALPHARETTA, Ga., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex” or the “Company”) today announced that it has closed the acquisition of substantially all of the...
Medovex Corporation Announces Definitive Agreement to Acquire the Pulmonary Biomedical Services and Patient Delivery Platform of Regenerative Medicine Solutions, LLC
October 16, 2018 08:00 ET
|
Medovex Corp.
ALPHARETTA, Ga., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX) (“Medovex”) announced today that it has signed a definitive agreement to acquire the pulmonary biomedical...